(Q46127804)

19 December 2017

title

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database (English)

1 reference

19 December 2017

author name string

O Kenneth Macdonald

1

1 reference

19 December 2017

Anthony V D'Amico

2

1 reference

19 December 2017

Natalia Sadetsky

3

1 reference

19 December 2017

Dennis C Shrieve

4

1 reference

19 December 2017

Peter R Carroll

5

1 reference

19 December 2017

publication date

3 December 2007

1 reference

19 December 2017

published in

Urologic Oncology

1 reference

19 December 2017

volume

26

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

271-275

1 reference

19 December 2017

Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Natural history of progression after PSA elevation following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Salvage radiotherapy for rising or persistent PSA after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.04.006

10.1016/J.UROLONC.2007.04.006

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

release_t6bua2tduvd7jipofhw2vagawe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t6bua2tduvd7jipofhw2vagawe

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18452818

1 reference

19 December 2017